NO971875L - Cathepsin 02 protease - Google Patents

Cathepsin 02 protease

Info

Publication number
NO971875L
NO971875L NO971875A NO971875A NO971875L NO 971875 L NO971875 L NO 971875L NO 971875 A NO971875 A NO 971875A NO 971875 A NO971875 A NO 971875A NO 971875 L NO971875 L NO 971875L
Authority
NO
Norway
Prior art keywords
cathepsin
protease
antibodies
proteins
relates
Prior art date
Application number
NO971875A
Other languages
English (en)
Other versions
NO971875D0 (no
Inventor
Dieter Broemme
Kathleen Okamoto
Original Assignee
Arris Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26987129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO971875(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/330,121 external-priority patent/US5736357A/en
Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp
Publication of NO971875D0 publication Critical patent/NO971875D0/no
Publication of NO971875L publication Critical patent/NO971875L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO971875A 1994-10-27 1997-04-23 Cathepsin 02 protease NO971875L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/330,121 US5736357A (en) 1994-10-27 1994-10-27 Cathespin O protease
US08/536,861 US6544767B1 (en) 1994-10-27 1995-10-02 Cathespin O2 protease
PCT/US1995/013820 WO1996013523A1 (en) 1994-10-27 1995-10-26 Cathepsin o2 protease

Publications (2)

Publication Number Publication Date
NO971875D0 NO971875D0 (no) 1997-04-23
NO971875L true NO971875L (no) 1997-06-12

Family

ID=26987129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971875A NO971875L (no) 1994-10-27 1997-04-23 Cathepsin 02 protease

Country Status (15)

Country Link
US (2) US6544767B1 (no)
EP (1) EP0783527B1 (no)
JP (1) JP3670666B2 (no)
KR (1) KR100473219B1 (no)
CN (1) CN1148382C (no)
AT (1) ATE317441T1 (no)
AU (1) AU711810B2 (no)
CA (1) CA2203765C (no)
DE (1) DE69534778T2 (no)
ES (1) ES2256849T3 (no)
FI (1) FI971777A7 (no)
HU (1) HU220960B1 (no)
NO (1) NO971875L (no)
NZ (1) NZ296003A (no)
WO (1) WO1996013523A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403304B1 (en) 1993-04-06 2002-06-11 Forsyth Dental Infirmary For Children Human osteoclast-specific and -related DNA sequences
US5501969A (en) 1994-03-08 1996-03-26 Human Genome Sciences, Inc. Human osteoclast-derived cathepsin
CA2209109A1 (en) 1995-10-30 1997-05-09 Thomas Joseph . Carr Method of inhibiting cathepsin k
CZ132798A3 (cs) * 1995-10-30 1999-02-17 Smithkline Beecham Corporation Inhibitory proteázy
US6586466B2 (en) 1995-10-30 2003-07-01 Smithkline Beecham Corporation Carbohydrazide-protease inhibitors
EP0812916A3 (en) * 1996-06-14 1998-12-09 Smithkline Beecham Corporation Cathepsin k gene
AU3802297A (en) * 1996-07-03 1998-01-21 Novadx, Inc. Method for detecting degenerative bone disease
GB9701888D0 (en) * 1997-01-30 1997-03-19 Ciba Geigy Ag Novel methods
US5948669A (en) * 1997-02-26 1999-09-07 Smithkline Beecham Corporation Rat cathepsin K polynucleotide and polypeptide sequence
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
US6346373B1 (en) * 1999-05-05 2002-02-12 Merck Frosst Canada & Co., Whole cell assay for cathepsin K activity
WO2001000798A2 (en) * 1999-06-25 2001-01-04 Hybritech Incorporated Cloning and expressing of human cathepsin k in mammalian cells
EP1229914A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
US6596715B1 (en) 1999-11-10 2003-07-22 Smithkline Beecham Corporation Protease inhibitors
WO2001053297A1 (en) 2000-01-20 2001-07-26 Merck & Co., Inc. Alpha v integrin receptor antagonists
AU4344101A (en) 2000-03-21 2001-10-03 Smithkline Beecham Corp Protease inhibitors
CA2425829A1 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases
JP4355287B2 (ja) * 2002-06-17 2009-10-28 株式会社ニチレイ ホッコクアカエビ由来の新規なカテプシンｌ様システインプロテアーゼ
AU2003256305A1 (en) * 2002-06-24 2004-01-06 Axys Pharmaceuticals, Inc. Peptidic compounds as cysteine protease inhibitors
JP2006528151A (ja) * 2003-07-21 2006-12-14 ノバルティス アクチエンゲゼルシャフト 骨転移、腫瘍増殖および腫瘍誘発骨量減少の処置におけるカテプシンｋ阻害剤およびビスホスホネートの組み合わせ
JP4553899B2 (ja) 2003-08-21 2010-09-29 メルク フロスト カナダ リミテツド カテプシンシステインプロテアーゼ阻害剤
WO2005029080A1 (en) * 2003-09-23 2005-03-31 Merck Frosst Canada Ltd. Whole cell assay for inhibitors of cathepsin k
WO2005093421A1 (de) * 2004-03-10 2005-10-06 Biovendor Laboratory Medicine, Inc. Enzymimmunoassay zur bestimmung von cathepsin k
US7029902B2 (en) * 2004-03-26 2006-04-18 Applera Corporation Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
AU2013202011C1 (en) * 2008-03-06 2015-10-01 Halozyme, Inc. In vivo temporal control of activatable matrix-degrading enzymes
US8901144B2 (en) 2013-02-07 2014-12-02 Scifluor Life Sciences, Llc Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
WO2014124302A1 (en) 2013-02-07 2014-08-14 Scifluor Life Sciences, Llc Fluorinated integrin antagonists
ES2864079T3 (es) 2014-05-30 2021-10-13 Pfizer Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos
WO2016134223A2 (en) 2015-02-19 2016-08-25 Scifluor Life Sciences, Inc. Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5501969A (en) 1994-03-08 1996-03-26 Human Genome Sciences, Inc. Human osteoclast-derived cathepsin
AU6333296A (en) 1996-06-14 1998-01-07 Human Genome Sciences, Inc. Cathepsin k gene

Also Published As

Publication number Publication date
CA2203765A1 (en) 1996-05-09
EP0783527B1 (en) 2006-02-08
KR970707153A (ko) 1997-12-01
US6544767B1 (en) 2003-04-08
HUT77049A (hu) 1998-03-02
US20030175937A1 (en) 2003-09-18
FI971777L (fi) 1997-04-25
EP0783527A4 (en) 1998-12-02
WO1996013523A1 (en) 1996-05-09
CN1170415A (zh) 1998-01-14
AU711810B2 (en) 1999-10-21
CN1148382C (zh) 2004-05-05
HU220960B1 (hu) 2002-07-29
ATE317441T1 (de) 2006-02-15
AU3968895A (en) 1996-05-23
NO971875D0 (no) 1997-04-23
DE69534778T2 (de) 2006-08-17
ES2256849T3 (es) 2006-07-16
DE69534778D1 (en) 2006-04-20
EP0783527A1 (en) 1997-07-16
FI971777A0 (fi) 1997-04-25
JP3670666B2 (ja) 2005-07-13
JPH10512740A (ja) 1998-12-08
FI971777A7 (fi) 1997-04-25
KR100473219B1 (ko) 2005-05-16
NZ296003A (en) 1999-10-28
CA2203765C (en) 2002-04-23

Similar Documents

Publication Publication Date Title
NO971875D0 (no) Cathepsin 02 protease
TR199600084A2 (tr) Sismanlamaya karsi proteinler.
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
PT733069E (pt) Antigenios ctla-8 de primata purificados e reagentes relacionados
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
FI905003L (fi) Glykosaminoglykan modifierat protein.
ATE394484T1 (de) Smad 6 und dessen anwendungen
WO1996027665A3 (en) Neuron-restrictive silencer factor proteins
ATE360695T1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
EP0758891A4 (en) HALOMETHYLAMIDES AS IL-1 BETA PROTEASE INHIBITORS
TR199500915A2 (tr) Peptidler.
ATE285474T1 (de) Haemophilus adhäsionsproteinen
NO963487D0 (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
DE69007556D1 (de) Protein-Hydrolyse.
SE9602822D0 (sv) New receptor
DE69522582D1 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
TR199501328A2 (tr) Alzheimer peptidi.
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
FI904357A0 (fi) Foerfarande foer aktivering av protein c.
EP0804556A4 (en) PROTEIN MODIFYING ENZYME
NO975534L (no) Imidazo-£1,5|-pyridin-avledete serinproteaseinhibitorer
SE9604439D0 (sv) New receptor
NL1000131C2 (nl) Monomere en oligomere bisfenyl-HALS-fosfieten als stabiliseermiddelen.
MX9203129A (es) Proteinas bmp-5.
MX9203296A (es) Proteinas bmp-7.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application